Iron Sucrose Injection USP
Description
Indications
Iron sucrose Injectable is a sterile aqueous complex, non-phylogenic aqueous complex containing 20 mg/mL of Iron suitable for intravenous administration.

Iron sucrose is dissociated into iron and sucrose by the reticuloendothelial system and iron is transferred form the blood to a bone marrow. The Ferritin the iron storage protein binds and sequesters iron into a nontoxic iron that is easily available. The iron binds to plasma transferring that is carries iron to extracellular fluid to supply to tissues. The transferring receptors presented in membrane binds transferrin iron complex which is then internalized in vesicles iron is released within the cell and transferrin-receptor complex is return to the cell membrane transferrin without iron is then releases to the plasma. The intracellular iron becomes hemoglobin on circulating red blood cells. Transferrin synthesis increased Ferritin production reduced in iron deficiency.
  • Iron sucrose injection is widely used in treatment of the iron deficiency and iron deficiency anemia and patients undergoing chronic Hemodialysis receiving supplemental erythropoietin therapy.
Product variants & features
 Product  Strength  Presentation  Features
SUCROFER  20 mg/ml   5 ml in glass ampoule  
  • Test dose not required
  • No over saturation of free iron
  • Does not cause histotoxicity unlike SFGC
  • Significant increase in Hb level
  • Nondialysable
  •  
 
 

Claris Lifesciences Ltd. All Rights Reserved.  :: Terms of Use  ::Privacy Policy ::Sitemap